Incyte Corp at BMO Capital Markets Prescription for Success Healthcare Conference (Virtual) Transcript
Hi. Hello, everyone. Good afternoon. Welcome to our afternoon session of the Virtual BMO Healthcare Conference. I'm George Farmer, Senior Biotechnology Analyst at BMO. It's my pleasure to have the management team of Incyte with us this afternoon, and we're going to talk about company progress. We have with us the CEO, Hervé Hoppenot; and the CFO, Christiana Stamoulis. We're going to have a fireside chat with both of them. Thank you very much for being here.
© -
Well, thank you for inviting us.
Questions & Answers
Yes, wonderful. So perhaps we can just start on a high level and talk about flagship product, Jakafi. You have provided us with some very bullish sales guidance, 2020 sales guidance of $1.88 billion to $1.95 billion this year that you maintained on your quarterly call. Can you tell us about your
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |